Yangonin 是一种新型 CB1 受体配体，对人重组 CB1 受体具有亲和力。它可能是干预 NF-Κb 依赖性病理状况的候选药物。

1. Yangonin is a novel CB receptor ligand, it exhibits affinity for the human recombinant CB receptor. 2. Yangonin could be a valuable candidate for the intervention of NF-κB-dependent pathological conditions such as inflammation.

500-62-9

C15H14O4

258.273

甲氧醉椒素;Y100550

DMSO:10 mM
Powder: -20°C for 3 years
In solvent: -80°C for 2 years